[Pneumocystis pneumonia in two breast cancer patients treated with docetaxel: an unusual adverse event of chemotherapy]

G Philippin-Lauridant; F Clatot; O Rigal; S Laberge-Le-Couteulx; C Guillemet; E Blot

doi:10.1016/j.revmed.2009.03.354

[Pneumocystis pneumonia in two breast cancer patients treated with docetaxel: an unusual adverse event of chemotherapy]

Rev Med Interne. 2010 Apr;31(4):e1-3. doi: 10.1016/j.revmed.2009.03.354. Epub 2009 Apr 29.

[Article in French]

Authors

G Philippin-Lauridant¹, F Clatot, O Rigal, S Laberge-Le-Couteulx, C Guillemet, E Blot

Affiliation

¹ Département d'oncologie médicale, centre Henri-Becquerel, rue d'Amiens, Rouen cedex, France.

PMID: 19406536
DOI: 10.1016/j.revmed.2009.03.354

Abstract

We report two cases of pneumocystis pneumonia in patients receiving chemotherapy for breast cancer. These case series emphasize the frailty of the patients as the causative role for occurrence of this uncommon complication of chemotherapy in breast cancer. We remind the importance of screening for unusual adverse events in frail patients receiving chemotherapy.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Breast Neoplasms / drug therapy*
Docetaxel
Female
Humans
Middle Aged
Pneumonia, Pneumocystis / chemically induced*
Taxoids / adverse effects*

Substances

Antineoplastic Agents
Taxoids
Docetaxel